Multidrug-Resistant Organisms on Patients’ Hands

at risk), and 3.1% (11 of 347 at risk) of patients newly acquired VRE, MRSA, and RGNB colonization, respectively. MRSA and VRE colonization were more likely to be persistent, with 37.3% (22 of 59) and 22.5% (16 of 71) of patients colonized at multiple visits, whereas RGNB colonization on the same patient's hand was never obtained at follow-up. Overall, 67.2% of MDRO-colonized patients (82 of 122) remained colonized at discharge.